Tonix Pharmaceuticals
TNXP
TNXP
16 hedge funds and large institutions have $158K invested in Tonix Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
31% less capital invested
Capital invested by funds: $227K → $158K (-$69.6K)
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$145K | |
| 2 | +$96.7K | |
| 3 | +$54.8K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$40K |
| 5 |
WS
Wedbush Securities
Los Angeles,
California
|
+$16.3K |
Top Sellers
| 1 | -$68.1K | |
| 2 | -$43.6K | |
| 3 | -$39K | |
| 4 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
-$19.6K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$17.7K |